Canada markets closed

FSD Pharma Inc. (HUGE)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.5400+0.0200 (+1.32%)
At close: 4:00PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2020-12-31
2019-12-31
2018-12-31
2017-12-31
Total Revenue
0
0
196.8192
65.1696
20.6306
Cost of Revenue
-
-
2,039
-
-
Gross Profit
-
-
-1,843
-
-
Operating Expenses
Research Development
11,551
7,833
-
-
-
Selling General and Administrative
26,250
18,868
22,862
18,193
2,823
Total Operating Expenses
41,669
30,601
25,979
18,622
2,823
Operating Income or Loss
-41,669
-30,601
-27,821
-18,557
-2,803
Interest Expense
132.186
235.581
158.0485
-
-
Total Other Income/Expenses Net
3,275
2,385
-11,839
1,883
-
Income Before Tax
-38,527
-28,452
-39,818
-16,674
-2,803
Income from Continuing Operations
-38,527
-28,452
-39,818
-16,674
-2,803
Net Income
-41,092
-31,800
-39,818
-16,674
-2,803
Net Income available to common shareholders
-41,092
-31,800
-39,818
-16,674
-2,803
Basic EPS
-
-2.64
-5.64
-2.80
-0.43
Diluted EPS
-
-2.64
-5.64
-2.80
-0.43
Basic Average Shares
-
12,044
7,056
5,905
6,565
Diluted Average Shares
-
12,044
7,056
5,905
6,565
EBITDA
-
-24,316
-37,251
-18,423
-2,803